This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
What the researchers found
The quality and intensity of the acute psychedelic experience predicted long-term antidepressant outcomes after psilocybin for treatment-resistant depression.
Read the original research
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression.
Frontiers in pharmacology, 8, 974
Citation
Roseman, Leor; Nutt, David J; Carhart-Harris, Robin L. (2018). Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression.. Frontiers in pharmacology, 8, 974. https://doi.org/10.3389/fphar.2017.00974